GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 1933 Industries Inc (OTCPK:TGIFF) » Definitions » Earnings per Share (Diluted)

1933 Industries (1933 Industries) Earnings per Share (Diluted) : $-0.02 (TTM As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is 1933 Industries Earnings per Share (Diluted)?

1933 Industries's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was $-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.02.

1933 Industries's EPS (Basic) for the three months ended in Jan. 2024 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.02.

1933 Industries's EPS without NRI for the three months ended in Jan. 2024 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.02.

During the past 3 years, the average EPS without NRIGrowth Rate was 30.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.10% per year.

During the past 13 years, 1933 Industries's highest 3-Year average EPS without NRI Growth Rate was 51.80% per year. The lowest was -54.40% per year. And the median was 25.30% per year.


1933 Industries Earnings per Share (Diluted) Historical Data

The historical data trend for 1933 Industries's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

1933 Industries Earnings per Share (Diluted) Chart

1933 Industries Annual Data
Trend Dec14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.06 -0.01 -0.03 -0.02

1933 Industries Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 -0.02 - -

Competitive Comparison of 1933 Industries's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


1933 Industries's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's PE Ratio distribution charts can be found below:

* The bar in red indicates where 1933 Industries's PE Ratio falls into.



1933 Industries Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

1933 Industries's Earnings Per Share (Diluted) for the fiscal year that ended in Jul. 2023 is calculated as

Diluted Earnings Per Share (A: Jul. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-10.116-0)/455.695
=-0.02

1933 Industries's Earnings Per Share (Diluted) for the quarter that ended in Jan. 2024 is calculated as

Diluted Earnings Per Share (Q: Jan. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.552-0)/469.152
=-0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


1933 Industries  (OTCPK:TGIFF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


1933 Industries Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of 1933 Industries's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


1933 Industries (1933 Industries) Business Description

Traded in Other Exchanges
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.